Results 201 to 210 of about 179,498 (360)

Feasibility and Implementation of an eHealth Dashboard for the Remote Monitoring of Dutch Patients With Chronic Myeloid Leukemia: Multimethods Approach. [PDF]

JMIR Cancer
Verweij L, Swillens JEM, Metsemakers SJJPM, Smit Y, Wener E, Ector GICG, Hermens RPMG, Blijlevens NMA.   +7 more
europepmc   +1 more source

scRNA-seq revealed the rules for CDR3 length pairing in TCR beta and alpha chains and BCR heavy and light chains in human and mice [PDF]

Jiaping Xiao, Jun Li, Yingjie Wu, Lanwei Zhu, Peng Qi, Yuanyuan Xu, Xinsheng Yao   +6 more
openalex   +1 more source

Supplementary Figure 2 from <i>In vitro</i> Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants

, 2023
Thomas O’Hare, Denise K. Walters, Eric P. Stoffregen, Taiping Jia, Paul W. Manley, Jürgen Mestan, Sandra W. Cowan‐Jacob, Francis Y. Lee, Michael C. Heinrich, Michael W. Deininger, Brian Druker   +10 more
openalex   +1 more source

Assessment and Correction of Non‐Linearity Effects for In Situ Rb‐Sr Geochronology Applied to High 87Rb/86Sr Mica

Geostandards and Geoanalytical Research, EarlyView.
Key Points Measurement of 86Sr at count rates < 1500 cps can result in statistical bias. Non‐linear signals in analogue detection mode (e.g., Rb) present a challenge for accurately dating high 87Rb/86Sr mica (> 1000). Accounting for these considerations, high 87Rb/86Sr mica are dated here with accuracies of ∼ 1%.
Duane C. Petts, William J. Davis, Simon E. Jackson, Jamie A. Cutts, Janina Czas, Alfredo Camacho   +5 more
wiley   +1 more source

BCR-ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ. [PDF]

MedComm (2020)
Lu X, Fang H, Liu Y, Liu C, Fang X, Matsunaga A, Mori SF, Zhang T, Wang G, Zhou GI, Yu M, Ding H, Cortes J, Cheng B, Hu T.   +14 more
europepmc   +1 more source

Assessment of critical survival mechanisms exploited by BCR-ABL1+ cells to evade tyrosine kinase inhibitor-induced death: determination of novel therapeutic targets in chronic myeloid leukaemia.

, 2014
Lisa Schafranek
openalex   +1 more source

Clinic Value of Blood Urea to Creatinine Ratio in Heart Failure Patients: A Systematic Review. [PDF]

Clin Cardiol
Cabanillas-Lazo M, Sernaqué-Mechato RA, Montes-Baldarrago A, Muñoz JV, Zapata VL, Alegre-Cordero I, Quispe-Vicuña C, Mayta-Tovalino F.   +7 more
europepmc   +1 more source

Specificity of dermatological adverse events of BCR-ABL tyrosine kinase inhibitors and their effect on quality of life of patients with chronic myeloid leukemia

, 2020
Е. А. Шатохина, Anna Turkina, Ekaterina Chelysheva, Oleg Shukhov, Anna Petrová, А. М. Ковригина, Л. С. Круглова, E. V. Ranenko, P. G. Nosikova   +8 more
openalex   +2 more sources

Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.

Blood, 2015
Yuh-Ying Yeh, H. Ozer, A. Lehman, K. Maddocks, Lianbo Yu, A. Johnson, J. Byrd   +6 more
semanticscholar   +1 more source

Immunophenotypic, Genetic, and Clinical Features Associated With RUNX1 Mutation in Acute Leukemias and Chronic Myeloid Neoplasms

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction RUNX1 is a commonly mutated transcriptional regulator of hematopoiesis in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Mutated RUNX1 (mRUNX1) may associate with cross‐lineage immunophenotypic aberrancy, presenting potential complications for blast lineage assignment at diagnosis. Methods Clinical and laboratory
Yi Han Xia, Eric McGinnis
wiley   +1 more source